1 Min Read
May 3 (Reuters) - Novo Nordisk A/S :
* Launches Xultophy® 100/3.6 (insulin degludec and liraglutide injection) in United States Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.